Could PCSO-524® be a potential adjuvant treatment to sleep therapy in the management of depression?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Could PCSO-524® be a potential adjuvant treatment to sleep therapy in the management of depression?

Published:2021-01 Issue: Volume:295 Page:113590
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Arakaki Felipe H.,Xerfan Ellen M.S.,Galduróz José Carlos F.,Tufik Sergio,Andersen Monica L.

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação de Amparo à Pesquisa do Estado de São Paulo

Associação Fundo de Incentivo à Pesquisa

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference15 articles.

1. So depression is an inflammatory disease, but where does the inflammation come from?;Berk;BMC Med,2013

2. Neuroinflammation in Alzheimer's disease: Current evidence and future directions;Calsolaro;Alzheimers Dement,2016

3. Global Health Estimates;Geneva: World Health Organization,2017

4. Lyprinol-is it a useful anti-inflammatory agent?;Doggrell;Evid Based Complement Alternat Med,2011

5. Neuroinflammation as a risk factor for attention deficit hyperactivity disorder;Dunn;Pharmacol Biochem Behav,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP